YiChang HEC ChangJiang Pharmaceutical Co. Ltd. Class H (HK:1558) has released an update.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. has announced a delay in the distribution of a circular that was to detail revisions of annual caps for continuing connected transactions and amendments to its Articles of Association. Initially set for release by 20 September 2024, the circular’s dispatch has been pushed to a date no later than 18 October 2024 due to the need for finalizing certain information. The circular is expected to include recommendations from the Independent Board Committee as well as advice from the Independent Financial Adviser.
For further insights into HK:1558 stock, check out TipRanks’ Stock Analysis page.